| abstract |
The present invention provides novel benzazepine compounds of Formula (1), or salts thereof, having vasopressin V 1a and V 2 antagonisms, and medical uses thereof. n In the formula, R 1 is optionally substituted C 1-6 alkyl, etc.; L is —C(═O)—NH—, etc.; Ring A 1 is a hydrocarbon ring, etc.; Ring A 2 is a hydrocarbon ring, etc.; and each of Rings A 1 and A 2 may have at least one substituent. |